Literature DB >> 20386873

["Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients].

C Krogias1, A Schröder, H Wiendl, R Hohlfeld, R Gold.   

Abstract

Currently, the hypothesis that altered venous hemodynamics might play a causative role in the pathogenesis of multiple sclerosis (MS) is being controversially discussed. This new "venous hypothesis" postulates that obstructions of the cervical venous system cause an increased pressure of the intracranial venous system and that in turn intracranial congestion disintegrates the blood-brain barrier initiating the inflammatory process in MS.The "venous hypothesis" is analyzed and evaluated with regard to the following aspects: first concerning the validity of published data, second with regard to the plausibility in view of the currently approved pathogenetic model of MS, and third with regard to the compatibility with preliminary neurosonological findings in a small but unselected cohort of patients at our department.The authors conclude that the "chronic cerebrospinal venous insufficiency (CCSVI)" cannot represent the exclusive pathogenetic factor in the pathogenesis of MS. In our cohort, only 20% of the patients fulfilled the required neurosonological features of CCSVI. So far, the pathogenetic relevance of these findings remains speculative. Thus, based on the current scientific position we cannot justify invasive "therapeutic" approaches, especially if they are performed outside of clinical trials.

Entities:  

Mesh:

Year:  2010        PMID: 20386873     DOI: 10.1007/s00115-010-2972-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  28 in total

1.  Postural dependency of the cerebral venous outflow.

Authors:  J M Valdueza; T von Münster; O Hoffman; S Schreiber; K M Einhäupl
Journal:  Lancet       Date:  2000-01-15       Impact factor: 79.321

2.  Transcranial color-coded duplex sonography of intracranial veins and sinuses in adults. Reference data from 130 volunteers.

Authors:  E Stolz; M Kaps; A Kern; S S Babacan; W Dorndorf
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

Review 3.  Inflammation in multiple sclerosis: the good, the bad, and the complex.

Authors:  Gianvito Martino; Luciano Adorini; Peter Rieckmann; Jan Hillert; Boris Kallmann; Giancarlo Comi; Massimo Filippi
Journal:  Lancet Neurol       Date:  2002-12       Impact factor: 44.182

4.  Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study.

Authors:  D Gay; M Esiri
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

5.  Incompetence of internal jugular valve in patients with primary exertional headache: a risk factor?

Authors:  F Doepp; J M Valdueza; S J Schreiber
Journal:  Cephalalgia       Date:  2007-11-16       Impact factor: 6.292

6.  Internal jugular venous flow measurement by means of a duplex scanner.

Authors:  H R Müller; G Hinn; M W Buser
Journal:  J Ultrasound Med       Date:  1990-05       Impact factor: 2.153

7.  Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.

Authors:  Bettina Kuenz; Andreas Lutterotti; Michael Khalil; Rainer Ehling; Claudia Gneiss; Florian Deisenhammer; Markus Reindl; Thomas Berger
Journal:  J Neuroimmunol       Date:  2005-10       Impact factor: 3.478

8.  Causes of venous ulceration: a new hypothesis.

Authors:  P D Coleridge Smith; P Thomas; J H Scurr; J A Dormandy
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-18

9.  A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.

Authors:  Paolo Zamboni; Roberto Galeotti; Erica Menegatti; Anna Maria Malagoni; Sergio Gianesini; Ilaria Bartolomei; Francesco Mascoli; Fabrizio Salvi
Journal:  J Vasc Surg       Date:  2009-12       Impact factor: 4.268

10.  The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis.

Authors:  F X Weilbach; A Chan; K V Toyka; R Gold
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

View more
  27 in total

1.  Sensitivity and specificity for screening of chronic cerebrospinal venous insufficiency using a multimodal non-invasive imaging approach in patients with multiple sclerosis.

Authors:  K Dolic; K Marr; V Valnarov; M G Dwyer; E Carl; J Hagemeier; C Kennedy; C Brooks; C Kilanowski; K Hunt; D Hojnacki; B Weinstock-Guttman; R Zivadinov
Journal:  Funct Neurol       Date:  2011 Oct-Dec

Review 2.  CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.

Authors:  Claudio Baracchini; José M Valdueza; Massimo Del Sette; Galina Baltgaile; Eva Bartels; Natan M Bornstein; Juergen Klingelhoefer; Carlos Molina; Kurt Niederkorn; Mario Siebler; Matthias Sturzenegger; Bernd E Ringelstein; David Russell; Laszlo Csiba
Journal:  J Neurol       Date:  2012-05-31       Impact factor: 4.849

Review 3.  CCSVI and MS: no meaning, no fact.

Authors:  Claudio Baracchini; Matteo Atzori; Paolo Gallo
Journal:  Neurol Sci       Date:  2012-05-09       Impact factor: 3.307

4.  Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis.

Authors:  Vanitha A Jagannath; Eugenio Pucci; Govindaraj V Asokan; Edward W Robak
Journal:  Cochrane Database Syst Rev       Date:  2019-05-31

Review 5.  Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies.

Authors:  Georgios Tsivgoulis; Theodoros N Sergentanis; Andrew Chan; Konstantinos Voumvourakis; Nikos Triantafyllou; Theodora Psaltopoulou; Ralf Gold; Christos Krogias
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

6.  Multiple sclerosis and chronic cerebrospinal venous insufficiency: a critical review.

Authors:  Amer M Awad; Ellen Marder; Ron Milo; Olaf Stüve
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

Review 7.  Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis.

Authors:  Andreas Laupacis; Erin Lillie; Andrew Dueck; Sharon Straus; Laure Perrier; Jodie M Burton; Richard Aviv; Kevin Thorpe; Thomas Feasby; Julian Spears
Journal:  CMAJ       Date:  2011-10-03       Impact factor: 8.262

8.  Intra- and extraluminal structural and functional venous anomalies in multiple sclerosis, as evidenced by 2 noninvasive imaging techniques.

Authors:  K Dolic; K Marr; V Valnarov; M G Dwyer; E Carl; Y Karmon; C Kennedy; C Brooks; C Kilanowski; K Hunt; A H Siddiqui; D Hojnacki; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

9.  Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency.

Authors:  J A Reekers; M J Lee; A M Belli; F Barkhof
Journal:  Cardiovasc Intervent Radiol       Date:  2010-12-07       Impact factor: 2.740

10.  The Central Vein: FLAIR Signal Abnormalities Associated with Developmental Venous Anomalies in Patients with Multiple Sclerosis.

Authors:  D M Rogers; L M Shah; R H Wiggins
Journal:  AJNR Am J Neuroradiol       Date:  2018-10-18       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.